Companies and Brands
FTC Probe of Herbalife “Pending” -- New York Post
Published:
Last Updated:
Herbalife was the target of a detailed charge by Pershing Square Capital Management chief William Ackman that the company is a “pyramid scheme.” Ackman has built up a large short position in Herbalife stock, and while there are plenty of others who believe he is wrong — including activist investor Carl Icahn and hedge fund manager Dan Loeb — the threat that the FTC will take some action against the nutrition and weight-loss firm will send investors running for the exits.
Just a week ago the FTC announced an investigation into an unnamed illegal pyramid scheme, and shares of both Herbalife and Nu Skin Enterprises Inc. (NYSE: NUS) dived. Even the fact that the investigation did not ultimately involve either firm indicates how jittery investors are about multilevel marketing firms like Herbalife.
Shares of Herbalife are down about 10.3% in premarket trading this morning, at $31.40 in a 52-week range of $24.24 to $73.00. Nu Skin’s shares are down about 3.7%, at $40.26 in a 52-week range of $32.36 to $62.01.
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.